Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2 Amplification: A Case Report.
Wen-Kuan HuangShih-Chiang HuangChien-Ming ChenPo Hung LinChiao-En WuCheng-Keng ChuangChun-Nan YehPublished in: JCO precision oncology (2023)